1. A systematic review of economic evaluations of tyrosine kinase inhibitors for non-small cell lung cancer (NSCLC). (24th July 2022) Authors: Byun, Joo-Young; Park, Sun-Kyeong; Ng, Boon Peng; Liu, Yi-Shao; Kim, Chae-Rin; Park, Chanhyun Journal: Expert opinion on pharmacotherapy Issue: Volume 23:Number 11(2022) Page Start: 1247 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗